Paragon Biosciences
Chicago, Illinoisparagonbiosci.com
Overview
Paragon Biosciences is a life science investment firm that creates, builds, and funds innovative biology-based companies focused on cell and gene therapy, adaptive biology, and advanced biotechnology.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| eMed | Mar 2026 | Series A | Co-investor |
| Castle Creek Biosciences | Feb 2025 | Debt | Co-investor |
| Evozyne | Sep 2023 | Series B | Co-investor |
| Emalex Biosciences | Nov 2022 | Series D | Co-investor |
| Castle Creek Biosciences | May 2022 | VC Round | Co-investor |
Key People
Jeffrey Aronin
Chairman and CEO
Spiro Katerinis
Chief Technology Officer
David Brill
Senior Vice President, Portfolio Management
Cole Ikkala
Vice President, Strategic Capital
Sietse Jonkman
Vice President, Portfolio Management
Fran Subotic
Director of Accounting Operations
Simone B.
Director, Finance
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
